Eton Pharmaceuticals's market cap is currently $383.27M. The company's EPS TTM is $-0.213; its P/E ratio is ―; Eton Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 31.64M	$ 21.25M	$ 21.83M	$ 39.00K	$ 959.00K
Gross Profit	$ 21.06M	$ 14.32M	$ 19.21M	$ -247.00K	$ 506.00K
Operating Income	$ -1.19M	$ -8.26M	$ -1.50M	$ -27.11M	$ -18.60M
EBITDA	$ -291.00K	$ -6.49M	$ -1.12M	$ -26.46M	$ -18.15M
Net Income	$ -936.00K	$ -9.78M	$ -2.96M	$ -28.83M	$ -18.04M
Balance Sheet
Cash & Short-Term Investments	$ 21.39M	$ 16.30M	$ 14.41M	$ 21.30M	$ 12.07M
Total Assets	$ 31.74M	$ 25.03M	$ 27.46M	$ 26.32M	$ 17.07M
Total Debt	$ 5.40M	$ 6.52M	$ 6.70M	$ 7.14M	$ 4.56M
Net Debt	$ -15.99M	$ -9.78M	$ -7.71M	$ -14.15M	$ -7.51M
Total Liabilities	$ 16.26M	$ 11.95M	$ 9.84M	$ 10.66M	$ 6.52M
Stockholders' Equity	$ 15.48M	$ 13.08M	$ 17.63M	$ 15.66M	$ 10.55M
Cash Flow
Free Cash Flow	$ 6.04M	$ 2.03M	$ -7.98M	$ -22.40M	$ -19.87M
Operating Cash Flow	$ 6.82M	$ 4.82M	$ -4.72M	$ -22.35M	$ -18.03M
Investing Cash Flow	$ -775.00K	$ -2.79M	$ -2.56M	$ -50.00K	$ -1.85M
Financing Cash Flow	$ -957.00K	$ -134.00K	$ 391.00K	$ 31.63M	$ 5.20M

Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

Income Statement >

Eton Pharmaceuticals Debt to Assets

Balance Sheet >

Eton Pharmaceuticals Cash Flow

Cash Flow >

Eton Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing